The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 12, 2025

Filed:

Oct. 21, 2022
Applicant:

Osteal Therapeutics, Inc., Dallas, TX (US);

Inventors:

Brian C. De Beaubien, Dallas, TX (US);

Brian Bowman, Dallas, TX (US);

Benjamin Arnold, Dallas, TX (US);

Erika Lin, Dallas, TX (US);

Kristen Pena, Dallas, TX (US);

Tina John, Dallas, TX (US);

Assignee:

Osteal Therapeutics, Inc., Dallas, TX (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61F 2/36 (2006.01); A61F 2/30 (2006.01); A61F 2/34 (2006.01); A61F 2/38 (2006.01); A61F 2/40 (2006.01); A61F 2/42 (2006.01);
U.S. Cl.
CPC ...
A61F 2/3609 (2013.01); A61F 2/30907 (2013.01); A61F 2/34 (2013.01); A61F 2/36 (2013.01); A61F 2/38 (2013.01); A61F 2/40 (2013.01); A61F 2/4202 (2013.01); A61F 2002/30387 (2013.01); A61F 2002/30405 (2013.01); A61F 2002/30507 (2013.01); A61F 2002/30517 (2013.01); A61F 2002/3055 (2013.01); A61F 2002/30593 (2013.01); A61F 2002/30672 (2013.01); A61F 2002/30677 (2013.01); A61F 2002/3068 (2013.01); A61F 2002/30784 (2013.01); A61F 2002/30825 (2013.01); A61F 2002/30827 (2013.01); A61F 2002/30878 (2013.01); A61F 2002/30919 (2013.01); A61F 2002/3401 (2013.01); A61F 2002/3613 (2013.01); A61F 2002/3621 (2013.01); A61F 2002/3647 (2013.01); A61F 2002/365 (2013.01); A61F 2002/368 (2013.01); A61F 2002/3694 (2013.01); A61M 2205/04 (2013.01);
Abstract

An orthopedic system for delivery of a therapeutic agent to a bone includes an elongate stem adapted to be inserted into an intramedullary canal, an inlet configured to receive the therapeutic agent, and one or more outlets configured to deliver the therapeutic agent to the bone. The elongate stem may comprise one or more protrusions to engage the bone, and one or more channels extending longitudinally therein, fluidly coupled to the inlet. The therapeutic agent flows from the inlet through the one or more channels and exits into the intramedullary canal through the one or more outlets. The system may be configured to allow one or more dimensions of the system to be adjusted to accommodate the anatomy of a patient.


Find Patent Forward Citations

Loading…